Cargando…

Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis

OBJECTIVES: To study baseline serum hepatocyte growth factor (s-HGF) as a predictor of spinal radiographic progression overall and by sex and to analyse factors correlated to changes in s-HGF in patients with AS. METHODS: At baseline and the 5-year follow-up, s-HGF was analysed with ELISA. Spinal ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deminger, Anna, Klingberg, Eva, Nurkkala, Merja, Geijer, Mats, Carlsten, Hans, Jacobsson, Lennart T H, Forsblad-d’Elia, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023989/ https://www.ncbi.nlm.nih.gov/pubmed/33106846 http://dx.doi.org/10.1093/rheumatology/keaa460

Ejemplares similares

Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes
por: Klingberg, Eva, et al.
Publicado: (2013)

A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis
por: Deminger, Anna, et al.
Publicado: (2018)

Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
por: Torres, L., et al.
Publicado: (2018)

Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study
por: Deminger, Anna, et al.
Publicado: (2017)

Physical function and sex differences in radiographic axial spondyloarthritis: a cross-sectional analysis on Bath Ankylosing Spondylitis Functional Index
por: Hallström, Magnus, et al.
Publicado: (2023)

Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex
por: Law, Lucy, et al.
Publicado: (2018)

Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
por: Deminger, A., et al.
Publicado: (2021)

A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis
por: Klingberg, Eva, et al.
Publicado: (2017)

Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment
por: Klingberg, Eva, et al.
Publicado: (2012)

Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study
por: Bengtsson, Karin, et al.
Publicado: (2019)

Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study
por: Forsblad-d’Elia, Helena, et al.
Publicado: (2013)

Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study
por: Bengtsson, Karin, et al.
Publicado: (2020)

Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from Sweden
por: Bengtsson, Karin, et al.
Publicado: (2023)

A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
por: Klingberg, Eva, et al.
Publicado: (2019)

Prevalence and factors related to sleep apnoea in ankylosing spondylitis
por: Wiginder, Adrian, et al.
Publicado: (2021)

Correction to: Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
por: Deminger, A., et al.
Publicado: (2021)

Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study
por: Lindström, Ulf, et al.
Publicado: (2016)

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study
por: Bengtsson, Karin, et al.
Publicado: (2017)

Infliximab Dose Reduction Sustains the Clinical Treatment Effect in Active HLAB27 Positive Ankylosing Spondylitis: A Two-Year Pilot Study
por: Mörck, Boel, et al.
Publicado: (2013)

Solitary syndesmophyte in odontoid process of a patient with ankylosing spondylitis
por: Min, Hong Ki, et al.
Publicado: (2022)

Characteristics and outcome of a first acute myocardial infarction in patients with ankylosing spondylitis
por: Södergren, Anna, et al.
Publicado: (2020)

Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case–control study based on national registers
por: Lindström, Ulf, et al.
Publicado: (2016)

Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study
por: Tuylu, Tugba, et al.
Publicado: (2014)

The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study
por: Exarchou, Sofia, et al.
Publicado: (2015)

Proposal of simplified CT syndesmophyte score (sCTSS) and comparison with CTSS in patients with ankylosing spondylitis
por: Min, Hong Ki, et al.
Publicado: (2023)

Patterns of comorbidity and disease characteristics among patients with ankylosing spondylitis—a cross-sectional study
por: Ljung, Lotta, et al.
Publicado: (2017)

Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study
por: Petcharat, Chonachan, et al.
Publicado: (2021)

Increased proportions of inflammatory T cells and their correlations with cytokines and clinical parameters in patients with ankylosing spondylitis from northern Sweden
por: Lejon, Kristina, et al.
Publicado: (2022)

Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden
por: Landgren, Anton Jonatan, et al.
Publicado: (2021)

Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study
por: Klingberg, Eva, et al.
Publicado: (2019)

ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis
por: Wang, Chin-Man, et al.
Publicado: (2012)

Regression of syndesmophyte after bone marrow transplantation for acute myeloid leukemia in a patient with ankylosing spondylitis: a case report
por: Yang, Hae Kyung, et al.
Publicado: (2012)

Decreased levels of T follicular helper (CD4+CXCR5+) cells and CD27+CD38+ and CD27+CD38− B cells in ankylosing spondylitis patients correlate with markers of inflammation
por: Lejon, Kristina, et al.
Publicado: (2022)

Preosteoclast plays a pathogenic role in syndesmophyte formation of ankylosing spondylitis through the secreted PDGFB — GRB2/ERK/RUNX2 pathway
por: Tang, Yulong, et al.
Publicado: (2023)

Bone mineral density by digital X-ray radiogrammetry is strongly decreased and associated with joint destruction in long-standing Rheumatoid Arthritis: a cross-sectional study
por: Forsblad-d'Elia, Helena, et al.
Publicado: (2011)

Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity
por: Sternes, P. R., et al.
Publicado: (2022)

The clinical relevance of the presence of bridging syndesmophytes on kyphosis correction and maintenance following pedicle subtraction osteotomy for thoracolumbar kyphotic deformity in ankylosing spondylitis: a comparative cohort study
por: Mao, Sai-hu, et al.
Publicado: (2018)

Association of adipokines, interleukin-6, and tumor necrosis factor-α concentrations with clinical characteristics and presence of spinal syndesmophytes in patients with ankylosing spondylitis: A cross-sectional study
por: Gonzalez-Lopez, Laura, et al.
Publicado: (2017)

Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot
por: Drivelegka, Panagiota, et al.
Publicado: (2020)

Role of resistin as a marker of inflammation in systemic lupus erythematosus
por: Almehed, Katarina, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rku93909kqegt6lo74u433fsqv